Yettwaleqqem
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Tuḍḍiwin n tɣawsiwin 2025TAFFA N TMUSNIWIN TUSNANIN
Ilugan n usḍibbi
Af-d ilugan unṣiben, arraten n umtawa d yileqman i d-ssufɣen yimusnawen d tedbirtin n ṣṣeḥḥa.
Iɣbula unṣiben, yettwamanenTuddsiwin tusnawin d tedbirtin n ṣṣeḥḥa
Isallen yettwaleqqmenAsenqed ussnan ameɣlal
Anekcum s war azal i yimseɣtayenI ɣur n temɣiwent n yimdanen n tẓṛi
Tisuffaɣ d ileqman ixataren
Wali isuffeɣen ineggura
Yettwaleqqem
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Tasleḍt n wul 2025
Akk yilugan (29 igmuḍ)
Imsizzel
AACE Consensus Statement: Algorithm for Management of Adults with Type 2 Diabetes – 2026 Update
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2026) on “AACE Consensus Statement: Algorithm for Management of Adults with Type 2 Diabetes – 2026 Update”. This u...
2026 AACE Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2026) on “2026 AACE Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes”. This...
2025 AACE Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2025) on “2025 AACE Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia”. This gui...
AACE Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease – 2025 Update
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2025) on “AACE Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Ba...
AACE Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2025) on “AACE Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update”. This algo...
2025 Consensus Statement on Management of Multiple Endocrine Neoplasia, Type 1
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2025) on “2025 Consensus Statement on Management of Multiple Endocrine Neoplasia, Type 1”. This AACE consensus sta...
2023 AACE Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2023) on “2023 AACE Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients wi...
2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2022) on “2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in...
2022 Consensus Statement on Minimally Invasive Procedures for Benign and Malignant Thyroid Lesions
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2022) on “2022 Consensus Statement on Minimally Invasive Procedures for Benign and Malignant Thyroid Lesions”. Thi...
2022 Consensus Statement on Immune Checkpoint Inhibitor-Mediated Endocrinopathies
American Association of Clinical Endocrinology
Official American Association of Clinical Endocrinology document (2022) on “2022 Consensus Statement on Immune Checkpoint Inhibitor-Mediated Endocrinopathies”. This consensus state...